| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918965 | Radiotherapy and Oncology | 2012 | 6 Pages |
Abstract
Our data showed a dose-dependent incidence of new hormonal deficits after GKS for pituitary adenoma. During planning definition, the risk of hypopituitarism could be reduced using the outlined safe dose-volume values.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gianluisa Sicignano, Marco Losa, Antonella del Vecchio, Giovanni Mauro Cattaneo, Piero Picozzi, Angelo Bolognesi, Pietro Mortini, Riccardo Calandrino,